Tevogen Bio Regains Nasdaq Compliance
3/25/2026
Impact: 80
Healthcare
Tevogen Bio Holdings Inc. (NASDAQ: TVGN) has received a notification from The Nasdaq Stock Market confirming that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1). This compliance is crucial for the company's continued listing on The Nasdaq Global Market.
AI summary, not financial advice
Share: